{
    "clinical_study": {
        "@rank": "125892", 
        "arm_group": [
            {
                "arm_group_label": "Bolus arm", 
                "arm_group_type": "Placebo Comparator", 
                "description": "two hourly dextrose boluses administered via an intravenous cannula"
            }, 
            {
                "arm_group_label": "infusion", 
                "arm_group_type": "Experimental", 
                "description": "10% dextrose infusion by burettes"
            }
        ], 
        "brief_summary": {
            "textblock": "NULL HYPOTHESIS \u2022 There is no difference in the incidence of hypoglycemia among preterms\n      receiving   either two hourly 10% dextrose boluses or 10% dextrose infusion by burettes\n      during the 72 hours of admission in Special Care Unit- Mulago Hospital.\n\n      ALTERNATE HYPOTHESIS\n\n      \u2022 Use of two hourly 10% dextrose boluses increases the incidence of hypoglycemia by 30%\n      compared to 10% dextrose infusion by burettes among preterms admitted to Special Care Unit\n      in the first 72 hours of admission."
        }, 
        "brief_title": "Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia", 
        "completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "condition": "Once a Preterm Developed Hypoglycemia, no More Blood Glucose Was Measured During the Study Period.", 
        "condition_browse": {
            "mesh_term": "Hypoglycemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - SELECTION CRITERIA Inclusion criteria\n\n          -  Preterms whose care givers/ mothers gave informed consent\n\n          -  Preterms whose age  was < 24 hours of life\n\n          -  Preterms with birth weight \u22651kg\n\n          -  Preterms with random blood sugar \u2265 2.6 mmol/l at admission into SCU.\n\n        Exclusion Criteria\n\n          -  Absence of a biological mother or abandoned baby\n\n          -  Presence of gross congenital abnormalities.\n\n          -  Very sick (Apgar score \u2264 5 at 5 minutes"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "24 Hours", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01688674", 
            "org_study_id": "2009/HD11/16712 U"
        }, 
        "intervention": {
            "arm_group_label": [
                "Bolus arm", 
                "infusion"
            ], 
            "intervention_name": "10% dextrose", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "September 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kampala", 
                    "country": "Uganda", 
                    "state": "Mulago", 
                    "zip": "+256"
                }, 
                "name": "Mulago Hospital"
            }
        }, 
        "location_countries": {
            "country": "Uganda"
        }, 
        "number_of_arms": "2", 
        "official_title": "Dextrose Boluses Versus Dextrose Infusions by Burettes in Prevention of Hypoglycemia Among Preterms Admitted at Mulago Hospital: An Open Label Randomized Clinical Trial", 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "Uganda: Research Ethics Committee", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Incidence proportion of hypoglycemia", 
            "safety_issue": "No", 
            "time_frame": "3months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01688674"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Makerere University", 
            "investigator_full_name": "KUTAMBA ELIZABETH", 
            "investigator_title": "Elizabeth Kutamba.R", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "survival measured as a proportion", 
            "safety_issue": "Yes", 
            "time_frame": "3months"
        }, 
        "source": "Makerere University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Makerere University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2012", 
        "why_stopped": "There was more benefit from the infusion arm compared to the bolus arm."
    }
}